Enginzyme Appoints Aymeric de Gantès as New CEO
28 May 2025 //
BUSINESSWIRE
EnginZyme Produces Key mRNA Vaccine Ingredient Using Biocatalysis
25 Oct 2023 //
BUSINESSWIRE
EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical
10 Feb 2021 //
BUSINESSWIRE

Market Place
Sourcing Support